Methadone Hydrochloride Molteni. Charakterystyka Produktu Leczniczego. Dostęp: 04.09.2022.
Grzegorzak G. Metadon w uzależnieniu od opiatów. Wiadomości Psychiatryczne 2002; 1.
Leppert W. Rola metadonu w leczeniu bólu u chorych na nowotwory. Medycyna Paliatywna 2012; 1: 1–12.
Kulikowska J, Celiński R, Nowicka J, Albert M, Kobek M, Droździok K. Methadone intoxication in a 3-week old infant –a case presentation. Problems of Forensic Sciences 2008; LXXV: 308–313.
Vignali C, Stramesi C, Morini L, Pozzi F, Groppi A. Methadone-related deaths. A ten year overview. Forensic Sci Int. 2015; 257: 172–176.
Akhgari M, Amini-Shirazi N, Iravani FS. Forensic Toxicology Perspectives of Methadone-associated Deaths in Tehran, Iran, a 7-year Overview. Basic Clin Pharmacol Toxicol. 2018; 122(4): 436–441.
Schulz M, Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics, Pharmazie 2003; 58, 447–474.
Caplehorn JR, Drummer OH. Methadone dose and post-mortem blood concentration. Drug Alcohol Rev. 2002; 21(4): 329–33.
Jones AW, Holmgren A, Ahlner J. Blood methadone concentrations in living and deceased persons: variations over time, subject demographics, and relevance of coingested drugs. J Anal Toxicol. 2012; 36(1): 12–8.
Ferrari A, Coccia CP, Bertolini A, Sternieri E. Methadone –metabolism, pharmacokinetics and interactions. Pharmacol Res. 2004; 50(6): 551–9.
Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005; 19(4): 13–24.
Yarema MC, Becker CE. Key concepts in postmortem drug redistribution. Clin Toxicol (Phila). 2005;43(4): 235–41.
Brockbals L, Staeheli SN, Gascho D, Ebert LC, Kraemer T, Steuer AE. Time-Dependent Postmortem Redistribution of Opioids in Blood and Alternative Matrices. J Anal Toxicol. 2018; 42(6): 365–374.
Alinejad S, Kazemi T, Zamani N, Hoffman RS, Mehrpour O. A systematic review of the cardiotoxicity of methadone. EXCLI J. 2015 ;14: 577–600.
Chugh SS, Socoteanu C, Reinier K, Waltz J, Jui J, Gunson K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med. 2008; 121(1): 66–71.
Lusetti M, Licata M, Silingardi E, Reggiani Bonetti L, Palmiere C. Therapeutic and recreational methadone cardiotoxicity. J Forensic Leg Med. 2016; 39: 80–4.
Kim HK, Manini A. Methadone-associated sudden cardiac death? Am J Med. 2008; 121(9): e11, author reply e13.
Ehret GB, Desmeules JA, Broers B. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology. Expert Opin Drug Saf. 2007; 6(3): 289–303.